Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A): Could It Be a Promising Biomarker and Therapeutic Target in Parkinson’s Disease?

Parkinson’s disease (PD) is an incurable neurodegenerative disease characterized by aggregation of pathological alpha-synuclein (α-syn) and loss of dopaminergic neuron in the substantia nigra. Inhibition of phosphorylation of the α-syn has been shown to mediate alleviation of PD-related pathology. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Sijia, Han, Chao, Xia, Yun, Wan, Fang, Hu, Junjie, Kou, Liang, Sun, Yadi, Wu, Jiawei, Li, Yunna, Zhou, Qiulu, Xiong, Nian, Huang, Jinsha, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857133/
https://www.ncbi.nlm.nih.gov/pubmed/34984583
http://dx.doi.org/10.1007/s12035-021-02670-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857133/
https://www.ncbi.nlm.nih.gov/pubmed/34984583
http://dx.doi.org/10.1007/s12035-021-02670-w

Ejemplares similares